Marshall Wace’s CME Group CME Stock Holding History

Marshall Wace’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-150,000	Closed	-$39.8M	–	2763
2025 Q1	$39.8M	Buy	+150,000	New	+$37M	0.05%	333

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Marshall Wace's CME Position: Q2 2026 in Review

Marshall Wace increased its CME Group (CME) stake by 179% in Q2 2026, buying an estimated $398M and bringing the position to 2,241,304 shares worth $495M. The position accounts for 0.39% of the portfolio, ranked #24.

Marshall Wace first reported a position in CME in Q2 2014 and has held it in 32 quarters since. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Marshall Wace held 2,241,304 shares of CME Group worth $495M as of Q2 2026.
Marshall Wace bought 1,437,086 CME Group shares in Q2 2026, an estimated $398M.
CME Group made up 0.39% of Marshall Wace's portfolio in Q2 2026, its #24 holding.
Marshall Wace first reported a position in CME Group in Q2 2014 and has held it in 32 quarters since.
1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.